Table 1 |
|
| Patient- and tumor characteristics | |
| Characteristics | No of patients (%) |
| All patients | 401 (100) |
| Age | |
| Median (range) | 58 (29–91) |
| < 50 years | 80 (20) |
| ≥ 50 years | 321 (80) |
| Mode of detection | |
| Screening detected | 167 (42) |
| Clinical signs | 232 (58) |
| Unknown | 2 |
| Tumor size | |
| ≤ 20mm | 263 (66) |
| > 20mm | 136 (34) |
| Unknown | 2 |
| Node status | |
| N0 | 233 (60) |
| N+ | 157 (40) |
| Unknown | 11 |
| NHG | |
| 1 | 77 (20) |
| 2 | 221 (56) |
| 3 | 94 (24) |
| Unknown | 9 |
| ER status | |
| Positive | 312 (80) |
| Negative | 77 (20) |
| Unknown | 12 |
| PR status | |
| Positive | 242 (62) |
| Negative | 147 (38) |
| Unknown | 12 |
| Surgery breast | |
| Mastectomy | 157 (39) |
| Breast concerving surgery | 243 (61) |
| Unknown | 1 |
| Surgery axilla | |
| Axillary dissection | 247 (63) |
| Sentinel node biopsy | 142 (37) |
| No Surgery (incl in clinical trial) | 12 |
|
Adjuvant treatment No adjuvant treatment |
137 (34) |
| Only Chemotherapy | 65 (16) |
| Only Endocrine therapy | 197 (49) |
| Missing | 2 |
| Radiotherapy | |
| Breast | 198 (49) |
| Locoregional lymph nodes | 35 (9) |
| Breast + locoregional | 39 (10) |
Abbreviations: N0= node negative, N+= node positive, NHG= Nottingham histological grade, ER= oestrogen receptor, PR= progesterone receptor.
Falck et al. BMC Cancer 2012 12:403 doi:10.1186/1471-2407-12-403
